{"schema_version":"secwatch.filing_event.v1","accession":"0001628280-26-024472","form_type":"8-K","ticker":"BDX","cik":"0000010795","company_name":"BECTON DICKINSON & CO","filed_at":"2026-04-09T23:59:59+00:00","discovered_at":"2026-05-14T18:02:31.920029+00:00","generated_at":"2026-05-15T06:45:34.064765+00:00","sec_items":["5.02","7.01","9.01"],"event_type":"leadership","sentiment":"neutral","materiality_score":0.6,"calibrated_materiality_score":0.6,"confidence":"high","headline":"BD EVP & Interventional President Richard Byrd to retire in June 2026","bullets":["Richard Byrd, EVP and President of Interventional segment, will retire after nearly 25 years at BD; will stay in role through June.","BD intends to name a successor prior to Byrd's retirement date; no replacement announced.","Byrd previously led Medication Delivery Solutions and Preanalytical Systems, and led manufacturing scale-up during COVID-19.","CEO Tom Polen cited Byrd's leadership in expanding Vascular Access Management and advancing 'One-Stick Hospital Stay' vision."],"urls":{"canonical":"https://secwatch.observer/filing/0001628280-26-024472","json":"https://secwatch.observer/filing/0001628280-26-024472.json","markdown":"https://secwatch.observer/filing/0001628280-26-024472.md","text":"https://secwatch.observer/filing/0001628280-26-024472.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/10795/000162828026024472/0001628280-26-024472-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/10795/000162828026024472/bdx-20260406.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-15T06:45:34.064765+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}